Devendra Kirti Pharmachem Pvt. Ltd.

Produces pharmaceuticals, chemicals, and botanical products since 1986 in Maharashtra.

1986 | Thane, Maharashtra (India) | Active
Last Updated: December 24, 2024

Devendra Kirti Pharmachem Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.39 M
  • Company Age 38 Year, 7 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 8.88 Cr
  • Revenue Growth 30.33%
  • Profit Growth 22.04%
  • Ebitda 1.66%
  • Net Worth -13.90%
  • Total Assets -22.15%

About Devendra Kirti Pharmachem

Devendra Kirti Pharmachem Pvt. Ltd. (DKPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 1986 and has a history of 38 years and seven months. Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.39 M.

The company currently has active open charges totaling ₹8.88 Cr.

Kushal Velaskar and Abhay Chaudhari serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    devendrakirtipharma.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U99999MH1986PTC040395

  • Company No.

    040395

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Jul 1986

  • Date of AGM

    30 Nov 2021

  • Date of Balance Sheet

    31 Mar 2021

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Devendra Kirti Pharmachem Pvt. Ltd. offer?

Devendra Kirti Pharmachem Pvt. Ltd. offers a wide range of products and services, including Vitamin Powder API, Ferric Ammonium Citrate Powder API, Heptahydrate, Zinc Sulphate Heptahydrate, Fertilizers and Soil Additives, Micronutrient Fertilizers, Chemical Reagents & Catalysts, Ammonium Compound.

Who are the key members and board of directors at Devendra Kirti Pharmachem?

Board Members (2)

NameDesignationAppointment DateStatus
Kushal Velaskar Country flag representing In Director 16-Dec-2016Current
Abhay Chaudhari Country flag representing In Director 18-Mar-2011Current

Financial Performance of Devendra Kirti Pharmachem.

Devendra Kirti Pharmachem Pvt. Ltd., for the financial year ended 2021, experienced significant growth in revenue, with a 30.33% increase. The company also saw a substantial improvement in profitability, with a 22.04% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.9%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
30.33%
Revenue from Operations
30.52%
Total Assets
-22.15%
Profit or Loss
22.04%
Net Worth
-13.90%
EBITDA
1.66%

What is the Ownership and Shareholding Structure of Devendra Kirti Pharmachem?

In 2021, Devendra Kirti Pharmachem had a promoter holding of 94.87% and a public holding of 5.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹88.77 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 5.10 Cr
  • Bassein Catholic Co-Operative Bank Limited : 2.08 Cr
  • The Bassein Catholic Co-Operative Bank Limited : 1.25 Cr
  • The Union Bank Of India Ltd. : 0.32 Cr
  • The Maharashtra State Financial Corporation : 0.09 Cr
  • Others : 0.05 Cr

Latest Charge Details

DateLenderAmountStatus
07 Mar 2018Others₹5.00 MOpen
28 Dec 2017Others₹1.70 CrOpen
30 Jun 2017Others₹0.60 MOpen
30 Jun 2017Others₹7.85 MOpen
18 Jul 2016Others₹5.50 MOpen

How Many Employees Work at Devendra Kirti Pharmachem?

Devendra Kirti Pharmachem has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Devendra Kirti Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devendra Kirti Pharmachem's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Devendra Kirti Pharmachem

Recent activity within the organization

  • Annual General Meeting

    Devendra Kirti Pharmachem Pvt. Ltd. last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.

    30 Nov 2021

  • Balance Sheet

    Devendra Kirti Pharmachem Pvt. Ltd. has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.

    31 Mar 2021

  • Charges

    A charge with Others amounted to Rs. 5.00 M with Charge ID 100162365 was registered on 07 Mar 2018.

    07 Mar 2018

  • Charges

    A charge with Others amounted to Rs. 17.00 M with Charge ID 100151027 was registered on 28 Dec 2017.

    28 Dec 2017

  • Charges

    A charge with Others amounted to Rs. 0.60 M with Charge ID 100119105 was registered on 30 Jun 2017.

    30 Jun 2017

  • Charges

    A charge with Others amounted to Rs. 7.85 M with Charge ID 100119107 was registered on 30 Jun 2017.

    30 Jun 2017

Frequently asked questions

  • Devendra Kirti Pharmachem Pvt. Ltd. was incorporated on 14 Jul 1986.

  • The authorized share capital of Devendra Kirti Pharmachem Pvt. Ltd. is ₹ 0.50 M and paid-up capital is ₹ 0.39 M.

  • Currently 2 directors are associated with Devendra Kirti Pharmachem Pvt. Ltd..

    • Kushal Jagdhar Velaskar
    • Abhay Yashwant Chaudhari
  • As per Ministry of Corporate Affairs (Mca), the registered address of Devendra Kirti Pharmachem Pvt. Ltd. is N-45 M.I.D.C. Tarapur Industrial Area Boisar West, India, Palghar, Maharashtra, 401506.

  • The corporate identification number (CIN) of Devendra Kirti Pharmachem Pvt. Ltd. is U99999MH1986PTC040395 and the company number is 040395 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Devendra Kirti Pharmachem Pvt. Ltd. is https://www.devendrakirtipharma.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Devendra Kirti Pharmachem Pvt. Ltd. has risen by 30.33%.

  • As Per 2021 financial reports, 14 employees are currently employed by Devendra Kirti Pharmachem Pvt. Ltd..

  • The financial reports for the fiscal year 2021 indicates that The net worth of Devendra Kirti Pharmachem Pvt. Ltd. has experienced an downturn of -13.90%.

  • As per the financial statements for fiscal Year 2021, The total open charges for Devendra Kirti Pharmachem Pvt. Ltd. amount to ₹ 8.88 Cr.

  • The most recent Balance Sheet for Devendra Kirti Pharmachem Pvt. Ltd. was filed with the ROC on 31 Mar 2021.

People also Viewed

Similar Companies Based on Drug Formulation & Development